Filing Details
- Accession Number:
- 0000899243-18-014450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-30 16:38:26
- Reporting Period:
- 2018-05-25
- Accepted Time:
- 2018-05-30 16:38:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1461993 | Melinta Therapeutics Inc. W | MLNT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106519 | N David Gill | C/O Melinta Therapeutics, Inc. 300 George Street, Suite 301 New Haven CT 06511 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-25 | 5,000 | $6.09 | 6,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
